When: Defended $548-$555 support with MACD histogram contracting AND RSI stabilizing above 45 on declining volume

Then: Add 50% of trimmed size

SELL with 30-50% trim (toward upper end), stop at $510, cap at 20-25% of defense allocation

• MACD histogram at negative 6.64 and expanding, price below all three major moving averages, RSI dropping toward oversold confirms regime shift
• Net debt at $17.58 billion against stockholders equity of only $6.72 billion equals leverage of approximately 2.6 times equity
• Forward PE of 16.6x looks attractive in isolation but faces compression as forward estimates assume margin recovery that technical and fundamental evidence both contradict
• Beta of 0.11 misleading given 12.9% underperformance against S&P 500 up 10.5% over six months, creating 23 percentage point gap
• Dividend yield of 2.46% insufficient protection against 10-15% potential share price decline
• ROE of 89% reflects financial engineering from share buybacks funded by debt rather than operational excellence
• 22% EPS erosion over two years despite 11% revenue growth undermines forward estimates
• Support zone at $545-$555 with Bollinger lower band at $543.39 and VWMA resistance at $578 presents unfavorable risk-reward
• Polymarket pricing 89% odds of zero Fed cuts in 2026 with inflation above 4.5% possible keeps discount rate elevated
• Smaller defense names (SIFCO, Ducommun, ATI) more volatile and less liquid with no balance sheet resilience to justify as defensive rotation

→ vs aggressive: Rotation into smaller defense names does not constitute risk reduction - smaller vendors are more volatile, less liquid, and equally exposed to government spending cycle deterioration

→ vs aggressive: Waiting for $530 weakness to exit is reactive rather than proactive - the trim should occur now at $544 to avoid crystallizing larger losses

→ vs neutral: BUY-on-confirmation at $545-$555 support zone requires the stock to actually hold those levels, risking 5-10% drawdown chasing a falling knife to capture only 5-6% bounce to VWMA resistance at $578

→ vs neutral: HOLD stance is incompatible with capital preservation in a confirmed downtrend - the risk-reward of waiting for confirmation is asymmetric to the downside

→ vs aggressive: Forward EPS growth of 21% and free cash flow of $6.91 billion are not protective when structural margin pressure continues and high-quality assets can still be poor risk-adjusted holdings at wrong price with wrong technical setup

Trim 40% of LMT position into $544-$555 range, maintain stop at $510, hold 60% as core exposure with $551.70 pivot as decision point; cap at 25% of defense allocation but anchor to 50-70% of benchmark weight

• MACD at negative 6.64 with price below all major moving averages confirms downtrend, but not a one-way decline
• FCF jumped 31% YoY to $6.91B with accelerating revenue trajectory (5.6% in 2025 vs 5.1% in 2024)
• $11.44B in deferred revenue provides multi-year demand visibility from US government and allies
• Forward PE of 16.6 is mid-range for defense, not high-multiple despite macro concerns
• 21% EPS growth to $32.72 is achievable if gross margins stabilize with operating leverage on accelerating revenue
• Combined dividend yield of 2.46% plus $3B buybacks creates ~5% total shareholder yield
• $8.56B operating cash flow and 1.19 current ratio support debt servicing capacity despite $17.58B net debt
• $551.70 SMA convergence not definitively resolved; one-day test at $544.50 needs confirmation over 3-5 sessions
• Defense budget visibility maintained in soft landing scenario with only 8% recession odds
• Iran conflict in month 6 with 4% formal declaration odds creates sustained spending environment
• Smaller defense vendors lack balance sheet to absorb continuing resolutions or F-35 monopoly economics
• 25% defense bucket cap is secondary control; primary discipline is benchmark weight targeting

→ vs aggressive: Melting ice cube framing is theater not analysis; rotation to smaller defense names increases risk given their inability to absorb continuing resolutions or match dividend aristocrat status

→ vs aggressive: Forward earnings trajectory of 21% EPS growth to $32.72 is not a trap if margins stabilize; operating leverage on accelerating revenue base makes this achievable

→ vs conservative: High net debt context is missing: $8.56B operating cash flow and 1.19 current ratio demonstrate debt servicing capacity, not financial engineering

→ vs conservative: Treating technical breakdown and fundamental thesis as the same thing is wrong; structural demand from interceptors, F-35, and European expansion has multi-year arc independent of September 2026 price action

→ vs conservative: Tightening stop to $515 using 2x ATR provides only ~$30 cushion with elevated $14.49 ATR; $510 aligns with March-April consolidation zone and gives appropriate room to breathe

→ vs conservative: Dividend dismissal is incomplete; 5% combined shareholder yield is real return of capital and trimming reduces claim on that stream

→ vs conservative: 25% defense bucket cap addresses wrong problem; primary fix is reducing to benchmark weight, not capping defense concentration